Seven Fleet Partners LP and Associates File Schedule 13D for CG Oncology, Inc.

Seven Fleet Partners LP, Seven Fleet Advisors LLC, and Dr. Brian Liu have filed a Schedule 13D with the SEC, disclosing their ownership of 1,540,819 shares of CG Oncology, Inc., representing approximately 1.9% of the company's outstanding common stock. The shares were purchased based on the belief that they were undervalued and represented an attractive investment opportunity. The Reporting Persons may consider increasing or decreasing their position in the company depending on market conditions and other factors. They have also entered into a Joint Filing Agreement to facilitate the joint filing of statements on Schedule 13D.